
Applied DNA Schedules Fiscal 2021 First Quarter Financial Results Conference Call and Webcast for Thursday, February 11, 2021
February 5th, 2021
Applied DNA Schedules Fiscal 2021 First Quarter Financial Results Conference Call and Webcast for Thursday, February 11, 2021
February 5th, 2021
Applied DNA Achieves Program Milestone in Development of Linear DNA Veterinary COVID-19 Vaccine
February 2nd, 2021
Applied DNA and TruTrace Technologies™ Unveil Complete Cannabis Product Validation and Authentication Solution
January 26th, 2021
Applied DNA Promotes Judy Murrah to COO
January 20th, 2021
Linea™ COVID-19 Assay Kit: Detection of Multiple SARS-CoV-2 Variants
January 19th, 2021
Business Update on COVID-19 Diagnostics and Testing
January 15th, 2021
Applied DNA Announces Closing of $15 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
January 13th, 2021
Pricing of $15M Registered Direct Offering
January 11th, 2021
Assay Kit Can Detect Gene Mutation Found in SARS-CoV-2 U.K. Variant B.1.1.7
January 8th, 2021